Indian market ends in negative territory on Wednesday
Drug manufacturer Lupin's net profit in the fourth quarter ended March 2017 fell 49.2 percent due to erosion of base business in the US, the company said while reporting its results on Wednesday.
Total revenues of the company declined 5.1 percent to Rs 4,253 crore, it said.
Key stocks that declined on Wednesday were Tata Motors, GAIL, Adani Ports, HUL and TCS while BHEL, Larsen & Toubro, Cipla, Dr Reddys Labs and Cola India declined.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
